MSD BioManufacturing Network Through its acquisition of Avecia Biologics, MSD Billingham is a leader in the contract process development and manufacture of microbial biopharmaceuticals. Proprietary expression systems include its pAVEway™ advanced protein expression technology. Its FDA-inspected manufacturing facility for recombinant protein biologics is sited in the north east UK, offering flexible capacity from 100L-5000L for all stages of the product pipeline. If you would like further information please contact: Bridget Hall
|
